Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 58

    No clinical trials need for Ayurveda, Unani, Siddha Medicines: Government of India

    No clinical trials need for Ayurveda, Unani, Siddha Medicines: Government of India

    Ruby Khatun Khatun11 July 2018 4:26 PM IST
    New Delhi: Through a recent notification, the Government of India has clarified that no clinical trials are required for issuing licenses patented or...
    Fortis deal: IHH likely to appear as winner with Rs 4,700-5,400 crore bid

    Fortis deal: IHH likely to appear as winner with Rs 4,700-5,400 crore bid

    Ruby Khatun Khatun10 July 2018 3:27 PM IST
    Mumbai: Malaysia's IHH Healthcare Berhad is likely to appear as the highest bidder of the latest Fortis Healthcare Bid with the controlling stake of...
    UKs unsafe syringes found their way to Indian hospitals: Report

    UK's unsafe syringes found their way to Indian hospitals: Report

    Ruby Khatun Khatun9 July 2018 10:26 AM IST
    LONDON: Syringes declared unsafe for use by the UK's state-funded National Health Service (NHS) found their way to India and are likely to have been...
    Trace and Track: Drug authentication system to be applicable on 300 brands

    Trace and Track: Drug authentication system to be applicable on 300 brands

    Ruby Khatun Khatun8 July 2018 12:50 PM IST
    INDORE: The proposed process of authentication and the Trace and Track mechanism of drugs to curb counterfeit and spurious medicines is going to be...
    Apollo Hospitals acquire 50 percent stake in Medics Super Speciality Hospital for Rs 91 crore

    Apollo Hospitals acquire 50 percent stake in Medics Super Speciality Hospital for Rs 91 crore

    Ruby Khatun Khatun7 July 2018 1:53 PM IST
    New Delhi: Apollo Hospitals said it has acquired 50 percent stake in a Lucknow-based 330-bed super speciality hospital project for a consideration of...
    Deferred: Ban on manufacturing of oxytocin formulations by pvt firms

    Deferred: Ban on manufacturing of oxytocin formulations by pvt firms

    Ruby Khatun Khatun6 July 2018 2:55 PM IST
    New Delhi: The scheduled ban on the manufacture of Oxytocin formulations by the private sector, which was to come into effect from July 1, has been...
    NPPA fixes prices of 58 formulations, details

    NPPA fixes prices of 58 formulations, details

    Ruby Khatun Khatun5 July 2018 1:55 PM IST
    New Delhi: Through a recent notification, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals and National...
    Fortis Bidding: Munjal-Burman stay away; IHH, Manipal-TPG still in fray

    Fortis Bidding: Munjal-Burman stay away; IHH, Manipal-TPG still in fray

    Ruby Khatun Khatun4 July 2018 2:00 PM IST
    New Delhi: Malaysia's IHH Healthcare and Manipal-TPG combine have put in fresh binding bids for cash-strapped healthcare chain while Munjal-Burman...
    Delhi needs to follow Andhra policy on Auto Disable syringes

    Delhi needs to follow Andhra policy on Auto Disable syringes

    Ruby Khatun Khatun3 July 2018 4:25 PM IST
    Andhra Pradesh is the first state in India to have come out with a policy around Auto-Disable (AD) syringes.In the national capital, many of the...
    Oxytocin ban: CDSCO raids in Bihar on Illegal Manufacturing, import

    Oxytocin ban: CDSCO raids in Bihar on Illegal Manufacturing, import

    Ruby Khatun Khatun2 July 2018 3:01 PM IST
    New Delhi: The Central Drug Standards Control Organisation (CDSCO) conducted raids at various locations in Bihar in a crackdown on illegal...
    Soon: New Calculations to come at Ceiling Prices for Essential Medicines

    Soon: New Calculations to come at Ceiling Prices for Essential Medicines

    Ruby Khatun Khatun1 July 2018 10:55 AM IST
    New Delhi: Essential medicines in the country are likely to become further reasonable and cheaper as the government is now considering a proposal to...
    Fortis moves to recover Rs 500 crore from Own Promoters

    Fortis moves to recover Rs 500 crore from Own Promoters

    Ruby Khatun Khatun30 Jun 2018 11:48 AM IST
    New Delhi: Fortis Healthcare said it has initiated legal action to recover about Rs 500 crore of funds allegedly taken out of the company by its...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok